why Neximmune Inc [NEXI] is a Good Choice for Investors After New Price Target of $125.00
Neximmune Inc [NASDAQ: NEXI] jumped around 3.95 points on Monday, while shares priced at $9.30 at the close of the session, up 73.83%. The company report on October 24, 2023 at 8:00 AM that NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes.